Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CDNA NYSE:CON NASDAQ:PRVA NASDAQ:WGS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCDNACareDx$12.79-0.4%$17.97$10.96▼$34.84$714.94M2.192.16 million shs875,600 shsCONConcentra Group Holdings Parent$19.70+0.3%$20.99$18.89▼$24.81$2.52BN/A897,355 shs698,700 shsPRVAPrivia Health Group$19.70$22.06$16.47▼$26.09$2.40B0.82968,080 shs784,411 shsWGSGeneDx$79.83-2.0%$77.34$25.32▼$117.75$2.32B2.01702,837 shs663,713 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCDNACareDx-2.13%+8.72%-31.99%-30.52%-30.29%CONConcentra Group Holdings Parent-2.52%-0.71%-7.18%-7.46%+1,965,599,900.00%PRVAPrivia Health Group-2.96%-4.88%-10.50%-14.98%+0.25%WGSGeneDx-1.81%+1.28%-10.40%-26.63%+140.69%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCDNACareDx4.1534 of 5 stars3.31.00.04.22.80.81.9CONConcentra Group Holdings Parent3.1348 of 5 stars3.50.02.50.02.70.01.3PRVAPrivia Health Group4.0883 of 5 stars3.54.00.00.03.23.31.9WGSGeneDx3.962 of 5 stars3.42.00.00.03.25.01.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCDNACareDx 2.67Moderate Buy$29.33129.35% UpsideCONConcentra Group Holdings Parent 3.00Buy$28.5044.67% UpsidePRVAPrivia Health Group 3.00Buy$28.3844.08% UpsideWGSGeneDx 2.78Moderate Buy$92.3315.66% UpsideCurrent Analyst Ratings BreakdownLatest CDNA, CON, PRVA, and WGS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/18/2025CDNACareDxCraig HallumSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$40.00 ➝ $26.007/9/2025PRVAPrivia Health GroupEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$30.00 ➝ $28.007/9/2025WGSGeneDxPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOverweight$110.006/30/2025WGSGeneDxGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$88.00 ➝ $115.005/28/2025PRVAPrivia Health GroupJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$29.00 ➝ $32.005/27/2025PRVAPrivia Health GroupBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$23.00 ➝ $24.005/15/2025WGSGeneDxGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$88.005/9/2025WGSGeneDxJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy$80.005/5/2025CDNACareDxStephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$40.00 ➝ $40.005/5/2025CDNACareDxHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$25.00 ➝ $25.005/1/2025WGSGeneDxTD SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$135.00 ➝ $110.00(Data available from 7/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCDNACareDx$333.79M2.13$1.35 per share9.44$7.06 per share1.81CONConcentra Group Holdings Parent$1.90B1.33$1.85 per share10.63$2.20 per share8.95PRVAPrivia Health Group$1.74B1.38$0.18 per share109.18$5.70 per share3.46WGSGeneDx$305.45M7.46$1.00 per share79.60$8.75 per share9.12Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCDNACareDx$52.55M$1.1511.12N/AN/A19.79%21.16%14.25%8/6/2025 (Estimated)CONConcentra Group Holdings Parent$166.54M$1.3414.7015.151.768.09%29.94%6.31%8/7/2025 (Confirmed)PRVAPrivia Health Group$14.39M$0.12164.1872.963.150.87%2.32%1.38%8/7/2025 (Estimated)WGSGeneDx-$52.29M-$1.41N/A38.20N/A-11.69%10.17%5.51%7/29/2025 (Estimated)Latest CDNA, CON, PRVA, and WGS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025CONConcentra Group Holdings Parent$0.37N/AN/AN/A$537.36 millionN/A8/7/2025Q2 2025PRVAPrivia Health Group$0.05N/AN/AN/A$466.97 millionN/A8/6/2025Q2 2025CDNACareDx$0.12N/AN/AN/A$90.72 millionN/A7/29/2025Q2 2025WGSGeneDx$0.09N/AN/AN/A$86.00 millionN/A5/7/2025Q1 2025CONConcentra Group Holdings Parent$0.31$0.32+$0.01$0.30$496.06 million$500.80 million4/30/2025Q1 2025CDNACareDx$0.06$0.09+$0.03-$0.19$84.56 million$84.69 million4/30/2025Q1 2025WGSGeneDx$0.11$0.28+$0.17-$0.23$79.90 million$87.12 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCDNACareDxN/AN/AN/AN/AN/ACONConcentra Group Holdings Parent$0.251.27%N/A18.66%N/APRVAPrivia Health GroupN/AN/AN/AN/AN/AWGSGeneDxN/AN/AN/AN/AN/ALatest CDNA, CON, PRVA, and WGS DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/8/2025CONConcentra Group Holdings Parentquarterly$0.06251.2%5/20/20255/20/20255/29/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCDNACareDxN/A4.113.84CONConcentra Group Holdings Parent5.181.101.10PRVAPrivia Health GroupN/A1.881.88WGSGeneDx0.203.253.07Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCDNACareDxN/ACONConcentra Group Holdings ParentN/APRVAPrivia Health Group94.48%WGSGeneDx61.72%Insider OwnershipCompanyInsider OwnershipCDNACareDx4.40%CONConcentra Group Holdings Parent6.60%PRVAPrivia Health Group10.70%WGSGeneDx29.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCDNACareDx74055.68 million53.23 millionOptionableCONConcentra Group Holdings Parent11,250128.17 million119.71 millionN/APRVAPrivia Health Group1,140121.92 million108.88 millionOptionableWGSGeneDx1,20028.53 million20.09 millionOptionableCDNA, CON, PRVA, and WGS HeadlinesRecent News About These CompaniesGeneDx CFO Sells More Than Half of His SharesJuly 25 at 2:40 PM | fool.comGeneDx Holdings Corp. (NASDAQ:WGS) Shares Sold by Legato Capital Management LLCJuly 23 at 7:15 AM | marketbeat.comJennison Associates LLC Acquires New Position in GeneDx Holdings Corp. (NASDAQ:WGS)July 23 at 4:20 AM | marketbeat.comWGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your RightsJuly 22 at 3:41 PM | globenewswire.comGeneDx Holdings Corp. (WGS) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseJuly 22 at 11:07 AM | zacks.comGeneDx (WGS) Expected to Announce Earnings on TuesdayJuly 22 at 8:02 AM | marketbeat.comWGS Investors Have Opportunity to Join GeneDx Holdings Corp. Investigation With the DJS Law GroupJuly 22 at 5:28 AM | prnewswire.comRosen Law Firm Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGSJuly 21, 2025 | prnewswire.comGeneDx Holdings Corp. (NASDAQ: WGS) Investor Alert: Schubert Jonckheer Investigates Possible False Statements and Insider TradingJuly 21, 2025 | prnewswire.comBrokerages Set GeneDx Holdings Corp. (NASDAQ:WGS) Price Target at $92.33July 21, 2025 | americanbankingnews.comMorse Asset Management Inc Takes $1.81 Million Position in GeneDx Holdings Corp. (NASDAQ:WGS)July 20, 2025 | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) Shares Acquired by New York State Common Retirement FundJuly 20, 2025 | marketbeat.comWGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. ...July 18, 2025 | gurufocus.comWGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your RightsJuly 18, 2025 | globenewswire.comHussman Strategic Advisors Inc. Makes New $2.79 Million Investment in GeneDx Holdings Corp. (NASDAQ:WGS)July 18, 2025 | marketbeat.comJackson Creek Investment Advisors LLC Acquires New Stake in GeneDx Holdings Corp. (NASDAQ:WGS)July 18, 2025 | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) Given Consensus Recommendation of "Moderate Buy" by AnalystsJuly 18, 2025 | marketbeat.comDoes GENEDX HOLDINGS (WGS) Have the Potential to Rally 26.17% as Wall Street Analysts Expect?July 17, 2025 | zacks.comPrincipal Financial Group Inc. Has $6.34 Million Stake in GeneDx Holdings Corp. (NASDAQ:WGS)July 17, 2025 | marketbeat.comWGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are ...July 16, 2025 | reflector.comRRosen Law Firm Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGSJuly 15, 2025 | prnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Leaders Set to Gain From Rising Military SpendBy Chris Markoch | July 5, 2025View 3 Defense Leaders Set to Gain From Rising Military SpendHow a Government Loan Changes the Game for Plug PowerBy Jeffrey Neal Johnson | July 4, 2025View How a Government Loan Changes the Game for Plug Power3 Catalysts Driving Plug Power’s Turnaround CaseBy Jeffrey Neal Johnson | July 18, 2025View 3 Catalysts Driving Plug Power’s Turnaround CaseD-Wave Is Rising Again Despite Dilution—What’s the Deal?By Nathan Reiff | July 7, 2025View D-Wave Is Rising Again Despite Dilution—What’s the Deal?Do They Know Something? Insiders & Congress Buy UnitedHealthBy Brian O'Connell | July 9, 2025View Do They Know Something? Insiders & Congress Buy UnitedHealthCDNA, CON, PRVA, and WGS Company DescriptionsCareDx NASDAQ:CDNA$12.79 -0.05 (-0.39%) Closing price 04:00 PM EasternExtended Trading$12.76 -0.03 (-0.27%) As of 07:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.Concentra Group Holdings Parent NYSE:CON$19.70 +0.06 (+0.31%) Closing price 03:58 PM EasternExtended Trading$20.03 +0.33 (+1.68%) As of 05:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company offers occupational and consumer health services, including workers' compensation injury care, urgent care, clinical testing, preventative care, and employer services, as well as wellness programs through occupational health centers and onsite clinics. It also provides Concentra Telemed, a telemedicine solution for the treatment of work-related injuries and illnesses, and employer services; pharmacy solution under the Concentra Pharmacy name; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. The company was founded in 1979 and is based in Mechanicsburg, Pennsylvania. Concentra Group Holdings Parent, Inc. is a subsidiary of Select Medical Corporation.Privia Health Group NASDAQ:PRVA$19.70 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$19.70 +0.00 (+0.03%) As of 07:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.GeneDx NASDAQ:WGS$79.83 -1.62 (-1.99%) Closing price 04:00 PM EasternExtended Trading$79.91 +0.08 (+0.10%) As of 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Intel's Turnaround Gains Credibility With Strong Q2 Report Qualcomm's Next Gear: A Growth Story Wall Street Might Be Missing Krispy Kreme: A Meme Stock Sugar Rush or a Sustainable Treat? From Zero to Hero? Why GoPro's Rally Could Be More Than It Seems CrowdStrike Scores Big With Gartner, But Valuation Is Stretched ServiceNow: The 2nd Wave of AI Spending Is Here Tractor Supply Revs Up on Forecast Hike and Bullish Signals A Smokin’ Hot Entry Point for Chipotle Stock Opens in Q3 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
